These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23285003)

  • 41. High molecular weight adiponectin inhibits vascular calcification in renal allograft recipients.
    Nomura-Nakayama K; Adachi H; Miyatake N; Hayashi N; Fujimoto K; Yamaya H; Yokoyama H
    PLoS One; 2018; 13(5):e0195066. PubMed ID: 29718962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Magnesium, calcium and PTH relationships in dialysis patients after magnesium repletion.
    Kenny MA; Casillas E; Ahmad S
    Nephron; 1987; 46(2):199-205. PubMed ID: 3600928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis.
    Sumida K; Molnar MZ; Potukuchi PK; Thomas F; Lu JL; Obi Y; Rhee CM; Streja E; Yamagata K; Kalantar-Zadeh K; Kovesdy CP
    Nephrol Dial Transplant; 2018 Feb; 33(2):264-273. PubMed ID: 28064159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High serum adiponectin concentration in children with chronic kidney disease.
    Möller KF; Dieterman C; Herich L; Klaassen IA; Kemper MJ; Müller-Wiefel DE
    Pediatr Nephrol; 2012 Feb; 27(2):243-9. PubMed ID: 21823040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
    Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
    Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential effect of baseline adiponectin on all-cause mortality in hemodialysis patients depending on initial body mass index. Long-term follow-up data of 4.5 years.
    Tsigalou C; Chalikias G; Kantartzi K; Tziakas D; Kampouromiti G; Vargemezis V; Konstantinides S; Ktenidou-Kartali S; Simopoulos K; Passadakis P
    J Ren Nutr; 2013 Jan; 23(1):45-56. PubMed ID: 22406123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Baseline Serum Magnesium Level and Its Variability in Maintenance Hemodialysis Patients: Associations with Mortality.
    Wu L; Cai K; Luo Q; Wang L; Hong Y
    Kidney Blood Press Res; 2019; 44(2):222-232. PubMed ID: 30921805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
    Navarro JF; Mora C; Macia M; Garcia J
    Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
    Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
    PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma adiponectin before and after kidney transplantation.
    Idorn T; Hornum M; Bjerre M; Jørgensen KA; Nielsen FT; Hansen JM; Flyvbjerg A; Feldt-Rasmussen B
    Transpl Int; 2012 Nov; 25(11):1194-203. PubMed ID: 22994569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients.
    Filippidis G; Liakopoulos V; Mertens PR; Kiropoulos T; Stakias N; Verikouki C; Patsidis E; Koukoulis G; Stefanidis I
    Blood Purif; 2005; 23(6):421-8. PubMed ID: 16141714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Associations of serum magnesium levels and calcium-magnesium ratios with mortality in patients with coronary artery disease.
    Li Q; Chen Q; Zhang H; Xu Z; Wang X; Pang J; Ma J; Ling W; Li D
    Diabetes Metab; 2020 Oct; 46(5):384-391. PubMed ID: 31870835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High stable serum adiponectin levels are associated with a better outcome in prevalent dialysis patients.
    Díez JJ; Estrada P; Bajo MA; Fernández-Reyes MJ; Grande C; del Peso G; Heras M; Molina A; Iglesias P; Sánchez-Villanueva R; Selgas R
    Am J Nephrol; 2009; 30(3):244-52. PubMed ID: 19468209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adiponectin and leptin in chronic kidney disease: causal factors or mere risk markers?
    Zoccali C; Mallamaci F
    J Ren Nutr; 2011 Jan; 21(1):87-91. PubMed ID: 21195927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of high-molecular-weight to total adiponectin ratio with pulse wave velocity in hemodialysis patients.
    Kato A; Odamaki M; Ishida J; Hishida A
    Nephron Clin Pract; 2008; 109(1):c18-24. PubMed ID: 18493156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adipocytokines leptin and adiponectin, and measures of malnutrition-inflammation in chronic renal failure: is there a relationship?
    Dervisoglu E; Eraldemir C; Kalender B; Kir HM; Caglayan C
    J Ren Nutr; 2008 Jul; 18(4):332-7. PubMed ID: 18558297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy.
    Jorsal A; Tarnow L; Frystyk J; Lajer M; Flyvbjerg A; Parving HH; Vionnet N; Rossing P
    Kidney Int; 2008 Sep; 74(5):649-54. PubMed ID: 18496510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis.
    Sakaguchi Y; Fujii N; Shoji T; Hayashi T; Rakugi H; Isaka Y
    Kidney Int; 2014 Jan; 85(1):174-81. PubMed ID: 23986148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypocalcemia, morbidity, and mortality in end-stage renal disease.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Hu L; O'Dea R; Murray DC; Barre PE
    Am J Nephrol; 1996; 16(5):386-93. PubMed ID: 8886175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.